Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity

NCT ID: NCT02745613

Last Updated: 2020-01-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates weather a family history of type 2 diabetes affects exercise induced improvements in insulin sensitivity in the hispanic population

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A family history of T2D (FH+) is a risk factor for developing insulin resistance (which precedes T2D) and T2D (Ryder et al., 2003). Exercise training on the other hand has been shown to improve insulin sensitivity and is highly effective to prevent/manage T2D. However it is not known if early signs of insulin resistance appear before being clinically diagnosed and if the benefits of exercise which prevent/cure T2D, are limited to the offspring of Hispanic T2D parents. Therefore, the proposed study will determine 1) if normoglycemic (normal blood glucose) offspring of T2D parents are insulin resistant, using the gold standard method to measure insulin sensitivity and metabolic flexibility (ability to switch between carbohydrate and fat oxidation) 2) if 8 weeks of exercise training improves insulin sensitivity and metabolic flexibility to the same extent in FH+ compared to normoglycemic offspring of parents without any history of T2D (FH-) and 3) if 8 weeks of exercise training will change the blood, lipid and molecular profiles relevant to insulin sensitivity to same extent in FH+ compared to offspring of parents without family history of T2D (FH-).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insulin Sensitivity/Resistance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Family history of T2D

The participants will undergo 8 weeks of combined exercise

Group Type EXPERIMENTAL

8 weeks of combined exercise intervention

Intervention Type OTHER

The subjects will undergo an 8 week combined exercise intervention

No Family history of T2D

The participants will undergo 8 weeks of combined exercise

Group Type EXPERIMENTAL

8 weeks of combined exercise intervention

Intervention Type OTHER

The subjects will undergo an 8 week combined exercise intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

8 weeks of combined exercise intervention

The subjects will undergo an 8 week combined exercise intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 ≤ Age ≤ 40 years
* 18 ≤ BMI ≤ 30 kg/m2
* Both parents are Mexican/Mexican-American)
* Sedentary lifestyle
* Less than 60 minutes/wk. of structured exercise
* Physical activity level ≤ 1.4

Exclusion Criteria

* Evidence of significant cardiovascular disease or diabetes
* A fasting blood glucose ≥100 mg/dL
* Screening blood pressure \>140/90
* Hyperlipidemia
* Use of drugs affecting energy metabolism or body weight
* Excess alcohol, drug abuse, and smoking
* Eating disorder or eating attitudes interfering with study
* Unwillingness to be abide by randomization
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Texas, El Paso

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sudip Bajpeyi

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sudip Bajpeyi, PhD.

Role: PRINCIPAL_INVESTIGATOR

University of Texas, El Paso

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Texas at El Paso

El Paso, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

755513-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.